A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
about
The role of CD44 in epithelial-mesenchymal transition and cancer developmentDownregulation of delta-aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancer.Epithelial-mesenchymal transition in prostate cancer: an overview.Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese PopulationsKnockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition.Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer.Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in SerumProstate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer.Prostate Cancer Stem Cells: Viewing Signaling Cascades at a Finer Resolution.P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.The Mesenchymal State Predicts Poor Disease-Free Survival in Resectable Non-Small Cell Lung Cancer.Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites.Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell.Visualization of early prostatic adenocarcinoma as a stem cell diseaseReversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells.Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma.Circulating SH2B1 is associated with an increased risk of gastric cancer.CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor ProgressionOverexpression of CD44 Standard Isoform Upregulates HIF-1α Signaling in Hypoxic Breast Cancer Cells
P2860
Q26771509-13983FFD-FBC2-4166-A53D-7DD14B1D4334Q33607424-7771A75C-2BF8-4410-B4AF-3A10CA487991Q33798864-5EA6F88C-2E40-4F49-AEB6-A742ADC3E59DQ35641403-ABD37946-CB38-41E4-B59C-153ED30EEAAFQ35781432-75AA3A5E-04D0-4D40-9472-EBBDEBD17918Q35955938-5E126C26-1A48-4E3D-9A98-A7E50DED4A6CQ36451478-2D456228-BD21-431D-9F7B-7FA05303431AQ38643148-1E8C5E07-F32E-4B1A-9C4C-69F96949A2B7Q38723375-26709EE4-51CC-4D3B-9B6C-5B9435AFC1B7Q38836825-8CB14916-A66B-4A24-A6B8-31773CC50FDFQ40203362-748209BB-99DB-48C7-9033-5B02323B6336Q41141633-FC5C740D-FD9B-4675-BA11-5E6F285CAD06Q41848132-75DCEEEF-6B09-4151-884B-1AA2C8A6E442Q41851423-53E7447E-023E-4C47-A2B9-DCB2F47CB2A8Q47435335-ADC9174D-88C7-42D2-803C-34C505AFE5BAQ51250068-4236CC47-476B-405A-8556-65256CB3885BQ54981648-67097B2B-81E1-4453-BAC9-2B935AFB4679Q58697956-0CB54B12-174D-498D-8394-3345C9AC9868Q58775614-90D9EDE3-1486-4076-83FF-1796C643435F
P2860
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
@ast
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
@en
type
label
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
@ast
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
@en
prefLabel
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
@ast
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
@en
P2093
P2860
P356
P1433
P1476
A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer
@en
P2093
Jiatong Chen
Minghao Zhang
Ning Jiang
Qiliang Cai
Shimiao Zhu
Xiaodan Niu
Yinghao Sun
P2860
P304
P356
10.18632/ONCOTARGET.2841
P407
P577
2015-01-01T00:00:00Z